FaDu In Vitro Protein Expression Analysis Assay (Immunoprecipitation)
CAT#: ITS-1122-YF3453
Target Cell Organism: Human
Target Cell Name: FaDu
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide FaDu-based In Vitro Protein Expression Analysis Assay (Immunoprecipitation) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
FaDu
Target Cell Organism
Human
Target Cell Background
FaDu is a cell line with epithelial morphology that was established in 1968 from a punch biopsy of a hypopharyngeal tumor removed from a 56-year-old, White, male patient with squamous cell carcinoma. This cell line is a suitable transfection host and has applications in cancer and immuno-oncology research.
Related Diseases
Squamous Cell Carcinoma
Research Area
Oncology
Assay Name
In Vitro Protein Expression Analysis Assay (Immunoprecipitation)
Short Description
FaDu-cell based In Vitro Protein Expression Analysis Assay (Immunoprecipitation)
Assay Description
For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.